[ad_1] Medicare on Tuesday announced the first 10 drugs to be selected for a price-negotiation…
JNJ
-
-
STOCK MARKET
The timing may be perfect for this dividend-stock fund if the market is getting close to a top
by userby user[ad_1] Investors see warnings every day and under all economic conditions that the stock market…
-
STOCK MARKET
Like shoppers at a retail store, IPO investors are demanding discounts and displaying price sensitivity
by userby user[ad_1] IPO investors, much like retail shoppers in recent years’ inflationary environment, are demanding clear…
-
STOCK MARKET
Eli Lilly on track to close with a higher market cap than J&J for first time since 1997
by userby user[ad_1] Eli Lilly & Co. was on track Friday to close with a greater market…
-
STOCK MARKET
Johnson & Johnson’s Kenvue IPO to command valuation of more than $40 billion in biggest public debut since 2021
by userby user[ad_1] A unit of Johnson & Johnson is headed for the biggest initial public offering…
-
STOCK MARKET
J&J’s Kenvue spinoff to hit IPO market this week in the biggest deal since late 2021
by userby user[ad_1] Johnson & Johnson’s consumer health company Kenvue is expected to hit the initial public…
-
STOCK MARKET
Johnson & Johnson swings to loss as it books multibillion-dollar charge to settle talc claims
by userby user[ad_1] Johnson & Johnson’s stock reversed early gains to trade down 2% Tuesday, after the…
-
[ad_1] Merck & Co.’s $10.8 billion acquisition of Prometheus Biosciences Inc., which it announced Sunday,…
-
STOCK MARKET
Drug manufacturer Catalent’s stock tumbles 25% after profit warning and CFO departure
by userby user[ad_1] Catalent Inc.’s stock tumbled 25% Friday, putting it on track for its second biggest…
-
STOCK MARKET
J&J’s proposal to settle talc lawsuits for $8.9 billion sends stock up the most in more than a year
by userby user[ad_1] Johnson & Johnson’s stock rose more than 3% Wednesday to put it on track…